WHO_HTM_TB_2009_420_9

For the continuation phase, the optimal dosing frequency is also daily for these
patients.

Grade Certainty of evidence
high
Grade Strength
strong
Grade Certainty of evidence label
in_the_evidence
Recommendation Direction
positive